正确认识生物标记物在全身性感染诊治中的价值
被引量:6
摘要
尽管抗生素以及复苏治疗近年来取得了长足的进步,全身性感染仍然是导致重症患者死亡的重要原因,病死率高达30%~70%。早期积极治疗对于改善感染患者预后具有重要临床意义。要想实现早期治疗,早期的诊断就显得十分重要和必要。全身性感染由于缺乏特异性的临床症状及体征,且表现各异,使得早期诊断变得非常复杂和困难。寻找早期诊断方法成为临床医生关注的热点。
出处
《中华急诊医学杂志》
CAS
CSCD
北大核心
2011年第12期1240-1242,共3页
Chinese Journal of Emergency Medicine
参考文献18
-
1Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003, 348 (16): 1546-1554.
-
2Marshall JC , Reinhart K. Biomarkers of sepsis [ J ]. Crit Care Med, 2009, 37 (7) : 2290-2298.
-
3Chan T, Gu F. Early diagnosis of sepsis using serum biomarkers [J]. Expert Rev Mol Diagn, 2011, 11 (5) : 487-496.
-
4Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis [ J]. Crit Care Med, 2006, 34 (7) : 1-8.
-
5Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations [J]. Crit Care Med, 2008, 36 (3) : 941-952.
-
6Limper M, de Kruif MD, Duits A J, et al. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever [J]. J Infect, 2010, 60 (6) : 409-416.
-
7Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? a muhicentre study [ J ]. Intensive Care Med, 2011, 37 (5) : 796-800.
-
8Petrikkos GL, Christofilopoulou SA, Tentolouris NK. Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections [ J ]. Eur J Clin Microbiol Infect Dis, 2005, 24 (4) : 272-275.
-
9Bouchon A, Faechetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock [ J ]. Nature, 2001, 410 (26) : 1103-1107.
-
10Bopp C, Hofer S, Bouehon A, et al. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation [ J ]. Eur J Anaeathesiol, 2009, 261 (6) : 504-507.
同被引文献46
-
1Chart T, Gu F. Early diagnosis of sepisis using serum biomarkers [J]. Exper Rev Mol Diagn, 2011, 11(5) : 487 -496.
-
2Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta- analysis[J]. Lancet Infect Dis, 2007, 7(3) : 210 -217.
-
3Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM - 1, a novel receptor ex- pressed on neutrophils and monoeytes [ J ]. J Immunol, 2000, 164(10) : 4991 -4995.
-
4Levy MM,Fink M,Marshall JC. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Critical Care Medicine,2003,(04):1250-1256.
-
5Levy MM,Dellinger RP,Townsend SR. The Surviving Sepsis Campaign:results of an international guideline-based performance improvement program targeting severe sepsis[J].Intensive Care Medicine,2010,(02):222-231.
-
6Kumar A,Robert D,Wood KE. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J].Critical Care Medicine,2006,(06):1589-1596.
-
7Limper M,de Kruif MD,Duits AJ. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever[J].Journal of Infection,2010,(06):409-416.
-
8Bouadma L,Luyt CE,Tubach F. PRORATA trial group:Use of procalcitonin to reduce patients'exposure to antibiotics in intensive care units (PRORATA trial):A multicentre randomised controlled trial[J].The Lancet,2010,(9713):463-474.
-
9Chan T,Gu F. Early diagnosis of sepsis using serum biomarkers[J].Expert Review of Molecular Diagnostics,2011,(05):487-496.
-
10Cuquemelle E,Soulis F,Villers D. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentren study[J].Intensive Care Medicine,2011,(05):796-800.
引证文献6
-
1谢剑锋,杨毅.一例重症腹腔感染的诊治[J].中华急诊医学杂志,2013,22(2):210-212. 被引量:1
-
2李英,邓超,计超,向群,殷宗宝.髓系细胞触发受体-1在低水平降钙素原脓毒症患者的诊断意义[J].中国急救医学,2014,34(2):132-134.
-
3史玉霞.髓系细胞触发受体-1在低水平降钙素原脓毒症患者的诊断意义[J].现代预防医学,2014,41(15):2828-2829. 被引量:1
-
4殷宗宝,曹玉芳,侯宇,向群.Presepsin在脓毒症早期患者中的临床应用[J].中华急诊医学杂志,2015,24(1):86-88. 被引量:12
-
5郑登滋,许钦,张珠平,林菊珊.sCD14-ST在SIRS重症患者合并脓毒症早期识别和病情评估中临床价值[J].医学理论与实践,2016,29(6):714-716. 被引量:3
-
6崔岩,张新超,银彩霞,范波.Presepsin(sCD_(14)-ST)检测对脓毒症急诊患者的诊断意义和预后评估价值[J].中华医院感染学杂志,2017,27(1):75-78. 被引量:18
二级引证文献35
-
1杨凯凯,孙国兴,杨焕英,王聪,杨婷.血清IL-15和sCD14-ST及急性时相蛋白水平对诊断肝炎肝硬化患者合并感染的价值[J].热带医学杂志,2021,21(12):1553-1557. 被引量:2
-
2黄波.presepsin联合降钙素原和C反应蛋白检测对脓毒症早期诊断及预后评估的价值[J].泰山医学院学报,2016,37(3):321-322. 被引量:1
-
3李真玉,赵华杰,赵君,陈兵.血清presepsin(sCD14-ST)对脓毒症早期诊断价值及预后意义[J].中华急诊医学杂志,2016,25(7):896-902. 被引量:22
-
4戴佳文,尤建权,于情,钱飞,汪丁松,刘宇,顾彬.肠脂肪酸结合蛋白及降钙素原联合测定在外伤性肠破裂早期诊断中的应用[J].中华急诊医学杂志,2016,25(8):1054-1057. 被引量:8
-
5何佳起,齐洪娜,张建军,王磊,李伟,王维展,李雅琴.心型脂肪酸结合蛋白和可溶性CD14亚型在丹参川芎嗪治疗脓毒症心肌损伤中的变化[J].实用医学杂志,2016,32(23):3924-3927. 被引量:13
-
6崔岩,张新超,银彩霞,范波.Presepsin(sCD_(14)-ST)检测对脓毒症急诊患者的诊断意义和预后评估价值[J].中华医院感染学杂志,2017,27(1):75-78. 被引量:18
-
7陈淼,林晓军,张红璇,方明.降钙素原和C反应蛋白在肺炎合并脓毒血症中的意义[J].中华急诊医学杂志,2017,26(7):807-810. 被引量:53
-
8刘沫然,肖铟,黄佳玲,田海容,才奇博.血必净注射液联合亚胺培南西司他丁治疗腹腔重症感染的临床观察[J].中国药房,2017,28(23):3271-3273. 被引量:11
-
9刘亚晶,李春明,亢宏山,王金荣,安立娟,齐洪娜,褚永果.舒血宁注射液对脓毒症患者Lac、Presepsin和NOS水平的影响[J].中成药,2017,39(9):1795-1799. 被引量:5
-
10周文杰,张楠,刘勤富,白吉佳,张珺,王晓红,杨晓军,马希刚.血浆Presepsin水平在脓毒症早期诊断中的价值研究[J].中华医院感染学杂志,2017,27(21):4846-4849. 被引量:11
-
1林超,吴文川.降钙素原在腹部大手术后感染诊治中应用价值[J].中国实用外科杂志,2013,33(8):704-706. 被引量:4
-
2龚旭,潘剑成,贺立新,刘芳欣.4例非典型性腰椎间隙感染诊治探讨分析[J].现代预防医学,2010,37(15):2992-2993. 被引量:2
-
3任国辉,叶任高.妇女尿路感染诊治的一些新概念[J].临床内科杂志,1994,11(3):17-18. 被引量:1
-
4艾斯卡尔·阿不拉.急性外科感染诊治[J].中国医药导报,2005,2(12):22-24.
-
5石岩,刘大为.降钙素原在全身性感染诊治中的研究进展[J].中华内科杂志,2011,50(5):444-446. 被引量:93
-
6乔金兰,杨秀琴.基层医院下尿路感染诊治[J].中国实用医药,2011,6(31):229-229. 被引量:1
-
7王奇.严重多发伤并特殊感染诊治中的错误及处理[J].华夏医学,1997,0(4):101-102.
-
8王建成,苏建荣.疑难血流感染诊治临床分析[J].河北医药,2013,35(9):1407-1408. 被引量:2
-
9陶松青.降钙素原在上尿路感染诊治中的意义[J].现代医药卫生,2013,29(21):3273-3275. 被引量:3
-
10邵小珍,戎辉.外伤性脾破裂53例围手术期处理[J].南通医学院学报,1996,16(3):388-388.